Role of dietary salt and potassium intake in cardiovascular health and disease: A review of the evidence

Mayo Clinic Proceedings

Volumn 88, Issue 9, 2013, Pages 987-995

  Aaron, Kristal J ^a   Sanders, Paul W ^a,b  

^a University of Alabama at Birmingham   (United States)

^b BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POTASSIUM; SODIUM CHLORIDE;

AGING; ALBUMINURIA; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; DATA BASE; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE COURSE; ENDOTHELIAL DYSFUNCTION; EVIDENCE BASED MEDICINE; HEART DISEASE; HUMAN; HYPERTENSION; KIDNEY DISEASE; MORTALITY; OBESITY; ORGAN INJURY; POPULATION RESEARCH; POTASSIUM INTAKE; PRACTICE GUIDELINE; PUBLIC HEALTH; RANDOMIZED CONTROLLED TRIAL (TOPIC); SALT INTAKE; TARGET ORGAN DAMAGE; VASCULAR DISEASE;

EID: 84884650569     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mayocp.2013.06.005     Document Type: Review

References (82)

1. Omran AR. The epidemiologic transition: a theory of the epidemiology of population change: 1971. Milbank Q. 2005; 83(4): 731-757.
2. Yoon SS, Burt V, Louis T, Carroll MD. Hypertension among adults in the United States, 2009-2010. NCHS Data Brief. 2012;(107): 1-8.
3. Heidenreich PA, Trogdon JG, Khavjou OA, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011;123(8): 933-944.
4. Tzoulaki I, Patel CJ, Okamura T, et al. A nutrient-wide association study on blood pressure. Circulation. 2012;126(21): 2456-2464.
5. Intersalt Cooperative Research Group. Intersalt: an international study of electrolyte excretion and blood pressure: results for 24 hour urinary sodium and potassium excretion. BMJ. 1988;297(6644): 319-328.
6. Cook NR, Cutler JA, Obarzanek E, et al. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the Trials of Hypertension Prevention (TOHP). BMJ. 2007;334(7599): 885-888.
7. Cook NR, Obarzanek E, Cutler JA, et al. Joint effects of sodium and potassium intake on subsequent cardiovascular disease: the Trials of Hypertension Prevention follow-up study. Arch Intern Med. 2009;169(1): 32-40.
8. Espeland MA, Kumanyika S, Yunis C, et al. Electrolyte intake and nonpharmacologic blood pressure control. Ann Epidemiol. 2002;12(8): 587-595.
9. Saint-Remy A, Somja M, Gellner K, Weekers L, Bonvoisin C, Krzesinski JM. Urinary and dietary sodium and potassium associated with blood pressure control in treated hypertensive kidney transplant recipients: an observational study. BMC Nephrol. 2012;13:121.
10. Mozaffarian D, Ludwig DS. Dietary guidelines in the 21st century: a time for food. JAMA. 2010;304(6): 681-682.
11. Strategies to Reduce Sodium Intake in the United States. Washington, DC: National Academy of Sciences; 2010.
12. Cogswell ME, Zhang Z, Carriquiry AL, et al. Sodium and potassium intakes among US adults: NHANES 2003-2008. Am J Clin Nutr. 2012;96(3): 647-657.
13. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650): 924-926.
14. Uhlig K, Macleod A, Craig J, et al. Grading evidence and recommendations for clinical practice guidelines in nephrology: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2006;70(12): 2058-2065.
15. Trials of Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure: the Trials of Hypertension Prevention, phase II. Arch Intern Med. 1997;157(6): 657-667.
16. Appel LJ, Espeland MA, Easter L, Wilson AC, Folmar S, Lacy CR. Effects of reduced sodium intake on hypertension control in older individuals: results from the Trial of Nonpharmacologic Interventions in the Elderly (TONE). Arch Intern Med. 2001;161(5): 685-693.
17. Applegate WB, Miller ST, Elam JT, et al. Nonpharmacologic intervention to reduce blood pressure in older patients with mild hypertension. Arch Intern Med. 1992;152(6): 1162-1166.
18. Blumenthal JA, Babyak MA, Hinderliter A, et al. Effects of the DASH diet alone and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: the ENCORE study. Arch Intern Med. 2010;170(2): 126-135.
19. Del Rio A, Rodriguez-Villamil JL. Metabolic effects of strict salt restriction in essential hypertensive patients. J Intern Med. 1993; 233(5): 409-414.
20. Dickinson KM, Keogh JB, Clifton PM. Effects of a low-salt diet on flow-mediated dilatation in humans. Am J Clin Nutr. 2009; 89(2): 485-490.
21. Haythornthwaite JA, Pratley RE, Anderson DE. Behavioral stress potentiates the blood pressure effects of a high sodium intake. Psychosom Med. 1992;54(2): 231-239.
22. He FJ, Marciniak M, Visagie E, et al. Effect of modest salt reduction on blood pressure, urinary albumin, and pulse wave velocity in white, black, and Asian mild hypertensives. Hypertension. 2009;54(3): 482-488.
23. Jessani S, Hatcher J, Chaturvedi N, Jafar TH. Effect of low vs. high dietary sodium on blood pressure levels in a normotensive Indo- Asian population. Am J Hypertens. 2008;21(11): 1238-1244.
24. Johnson AG, Nguyen TV, Davis D. Blood pressure is linked to salt intake and modulated by the angiotensinogen gene in normotensive and hypertensive elderly subjects. J Hypertens. 2001;19(6): 1053-1060.
25. Jula AM, Karanko HM. Effects on left ventricular hypertrophy of long-term nonpharmacological treatment with sodium restriction in mild-to-moderate essential hypertension. Circulation. 1994;89(3): 1023-1031.
26. Kojuri J, Rahimi R. Effect of "no added salt diet" on blood pressure control and 24 hour urinary sodium excretion in mild to moderate hypertension. BMC Cardiovasc Disord. 2007;7:34.
27. Sacks FM, Svetkey LP, Vollmer WM, et al; DASH-Sodium Collaborative Research Group. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N Engl J Med. 2001;344(1): 3-10.
28. Schorr U, Turan S, Distler A, Sharma AM. Relationship between ambulatory and resting blood pressure responses to dietary salt restriction in normotensive men. J Hypertens. 1997; 15(8): 845-849.
29. Sciarrone SE, Beilin LJ, Rouse IL, Rogers PB. A factorial study of salt restriction and a low-fat/high-fibre diet in hypertensive subjects. J Hypertens. 1992;10(3): 287-298.
30. Slagman MC, Kwakernaak AJ, Yazdani S, et al. Vascular endothelial growth factor C levels are modulated by dietary salt intake in proteinuric chronic kidney disease patients and in healthy subjects. Nephrol Dial Transplant. 2012;27(3): 978-982.
31. Svetkey LP, Simons-Morton DG, Proschan MA, et al. Effect of the Dietary Approaches to Stop Hypertension diet and reduced sodium intake on blood pressure control. J Clin Hypertens (Greenwich). 2004;6(7): 373-381.
32. Swift PA, Markandu ND, Sagnella GA, He FJ, MacGregor GA. Modest salt reduction reduces blood pressure and urine protein excretion in black hypertensives: a randomized control trial. Hypertension. 2005;46(2): 308-312.
33. Todd AS, Macginley RJ, Schollum JB, et al. Dietary salt loading impairs arterial vascular reactivity. Am J Clin Nutr. 2010;91(3): 557-564.
34. van Berge-Landry H, James GD. Serum electrolyte, serum protein, serum fat and renal responses to a dietary sodium challenge: allostasis and allostatic load. Ann Hum Biol. 2004;31(4): 477-487.
35. Vollmer WM, Sacks FM, Ard J, et al. Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASHsodium trial. Ann Intern Med. 2001;135(12): 1019-1028.
36. Whelton PK, Appel LJ, Espeland MA, et al; TONE Collaborative Research Group. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). JAMA. 1998;279(11): 839-846.
37. Burke V, Beilin LJ, Cutt HE, Mansour J, Wilson A, Mori TA. Effects of a lifestyle programme on ambulatory blood pressure and drug dosage in treated hypertensive patients: a randomized controlled trial. J Hypertens. 2005;23(6): 1241-1249.
38. Cappuccio FP, Markandu ND, Carney C, Sagnella GA, MacGregor GA. Double-blind randomised trial of modest salt restriction in older people. Lancet. 1997;350(9081): 850-854.
39. Akita S, Sacks FM, Svetkey LP, Conlin PR, Kimura G; Group DA- S.T.C.R. Effects of the Dietary Approaches to Stop Hypertension (DASH) diet on the pressure-natriuresis relationship. Hypertension. 2003;42(1): 8-13.
40. Dishy V, Sofowora GG, Imamura H, et al. Nitric oxide production decreases after salt loading but is not related to blood pressure changes or nitric oxide-mediated vascular responses. J Hypertens. 2003;21(1): 153-157.
41. Maruthur NM, Wang NY, Appel LJ. Lifestyle interventions reduce coronary heart disease risk: results from the PREMIER Trial. Circulation. 2009;119(15): 2026-2031.
42. Vaidya A, Bentley-Lewis R, Jeunemaitre X, Adler GK, Williams JS. Dietary sodium alters the prevalence of electrocardiogram determined left ventricular hypertrophy in hypertension. Am J Hypertens. 2009;22(6): 669-673.
43. Berry SE, Mulla UZ, Chowienczyk PJ, Sanders TA. Increased potassium intake from fruit and vegetables or supplements does not lower blood pressure or improve vascular function in UK men and women with early hypertension: a randomised controlled trial. Br J Nutr. 2010;104(12): 1839-1847.
44. Brancati FL, Appel LJ, Seidler AJ, Whelton PK. Effect of potassium supplementation on blood pressure in African Americans on a low-potassium diet: a randomized, double-blind, placebocontrolled trial. Arch Intern Med. 1996;156(1): 61-67.
45. Braschi A, Naismith DJ. The effect of a dietary supplement of potassium chloride or potassium citrate on blood pressure in predominantly normotensive volunteers. Br J Nutr. 2008; 99(6): 1284-1292.
46. Grimm RH Jr, Neaton JD, Elmer PJ, et al. The influence of oral potassium chloride on blood pressure in hypertensive men on a low-sodium diet. N Engl J Med. 1990;322(9): 569-574.
47. Gu D, He J, Wu X, Duan X, Whelton PK. Effect of potassium supplementation on blood pressure in Chinese: a randomized, placebo-controlled trial. J Hypertens. 2001;19(7): 1325-1331.
48. He FJ, Marciniak M, Carney C, et al. Effects of potassium chloride and potassium bicarbonate on endothelial function, cardiovascular risk factors, and bone turnover in mild hypertensives. Hypertension. 2010;55(3): 681-688.
49. Naismith DJ, Braschi A. The effect of low-dose potassium supplementation on blood pressure in apparently healthy volunteers. Br J Nutr. 2003;90(1): 53-60.
50. Patki PS, Singh J, Gokhale SV, Bulakh PM, Shrotri DS, Patwardhan B. Efficacy of potassium and magnesium in essential hypertension: a double-blind, placebo controlled, crossover study. BMJ. 1990;301(6751): 521-523.
51. Siani A, Strazzullo P, Giacco A, Pacioni D, Celentano E, Mancini M. Increasing the dietary potassium intake reduces the need for antihypertensive medication. Ann Intern Med. 1991;115(10): 753-759.
52. Smith SR, Klotman PE, Svetkey LP. Potassium chloride lowers blood pressure and causes natriuresis in older patients with hypertension. J Am Soc Nephrol. 1992;2(8): 1302-1309.
53. Whelton PK, Buring J, Borhani NO, et al; Trials of Hypertension Prevention (TOHP) Collaborative Research Group. The effect of potassium supplementation in persons with a high-normal blood pressure: results from phase I of the Trials of Hypertension Prevention (TOHP). Ann Epidemiol. 1995;5(2): 85-95.
54. Wu G, Tian H, Han K, Xi Y, Yao Y, Ma A. Potassium magnesium supplementation for four weeks improves small distal artery compliance and reduces blood pressure in patients with essential hypertension. Clin Exp Hypertens. 2006;28(5): 489-497.
55. Hypertension Prevention Trial Research Group. The Hypertension Prevention Trial: three-year effects of dietary changes on blood pressure. Arch Intern Med. 1990;150(1): 153-162.
56. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels: results of the Trials of Hypertension Prevention, Phase I. JAMA. 1992;267(9): 1213-1220.
57. Al-Solaiman Y, Jesri A, Mountford WK, Lackland DT, Zhao Y, Egan BM. DASH lowers blood pressure in obese hypertensives beyond potassium, magnesium and fibre. J Hum Hypertens. 2010;24(4): 237-246.
58. China Salt Substitute Study Collaborative Group. Salt substitution: a low-cost strategy for blood pressure control among rural Chinese: a randomized, controlled trial. J Hypertens. 2007; 25(10): 2011-2018.
59. Cook NR, Kumanyika SK, Cutler JA. Effect of change in sodium excretion on change in blood pressure corrected for measurement error: the Trials of Hypertension Prevention, Phase I. Am J Epidemiol. 1998;148(5): 431-444.
60. Geleijnse JM, Witteman JC, Bak AA, den Breeijen JH, Grobbee DE. Reduction in blood pressure with a low sodium, high potassium, high magnesium salt in older subjects with mild to moderate hypertension. BMJ. 1994;309(6952): 436-440.
61. Gilleran G, O'Leary M, Bartlett WA, Vinall H, Jones AF, Dodson PM. Effects of dietary sodium substitution with potassium and magnesium in hypertensive type II diabetics: a randomised blind controlled parallel study. J Hum Hypertens. 1996; 10(8): 517-521.
62. Mu J, Liu Z, Liu F, Xu X, Liang Y, Zhu D. Family-based randomized trial to detect effects on blood pressure of a salt substitute containing potassium and calcium in hypertensive adolescents. Am J Hypertens. 2009;22(9): 943-947.
63. Nowson CA, Morgan TO, Gibbons C. Decreasing dietary sodium while following a self-selected potassium-rich diet reduces blood pressure. J Nutr. 2003;133(12): 4118-4123.
64. Sarkkinen ES, Kastarinen MJ, Niskanen TH, et al. Feasibility and antihypertensive effect of replacing regular salt with mineral salt-rich in magnesium and potassium in subjects with mildly elevated blood pressure. Nutr J. 2011;10:88.
65. Whelton PK, Kumanyika SK, Cook NR, et al; Trials of Hypertension Prevention Collaborative Research Group. Efficacy of nonpharmacologic interventions in adults with high-normal blood pressure: results fromphase 1 of the Trials of Hypertension Prevention. Am J Clin Nutr. 1997;65(2, suppl):652S-660S.
66. Chang HY, Hu YW, Yue CS, et al. Effect of potassium-enriched salt on cardiovascular mortality and medical expenses of elderly men. Am J Clin Nutr. 2006;83(6): 1289-1296.
67. MacGregor GA, Markandu ND, Sagnella GA, Singer DR, Cappuccio FP. Double-blind study of three sodium intakes and long-term effects of sodium restriction in essential hypertension. Lancet. 1989;2(8674): 1244-1247.
68. Seals DR, Tanaka H, Clevenger CM, et al. Blood pressure reductions with exercise and sodium restriction in postmenopausal women with elevated systolic pressure: role of arterial stiffness. J Am Coll Cardiol. 2001;38(2): 506-513.
69. Coxson PG, Cook NR, Joffres M, et al. Mortality benefits from US population-wide reduction in sodium consumption: projections from 3 modeling approaches. Hypertension. 2013;61(3): 564-570.
70. Meneely GR, Ball CO. Experimental epidemiology of chronic sodium chloride toxicity and the protective effect of potassium chloride. Am J Med. 1958;25(5): 713-725.
71. Stolarz-Skrzypek K, Kuznetsova T, Thijs L, et al. Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. JAMA. 2011;305(17): 1777-1785.
72. Bochud M, Guessous I, Bovet P. Urinary sodiumexcretion and cardiovascular disease mortality [letter]. JAMA. 2011;306(10):1084.
73. de Abreu-Silva EO, Marcadenti A. Urinary sodium excretion and cardiovascular disease mortality [letter]. JAMA. 2011; 306(10): 1085-1086.
74. Labarthe DR, Briss PA. Urinary sodium excretion and cardiovascular disease mortality [letter]. JAMA. 2011;306(10): 1084-1085.
75. He FJ, Appel LJ, Cappuccio FP, de Wardener HE, MacGregor GA. Does reducing salt intake increase cardiovascular mortality? Kidney Int. 2011;80(7): 696-698.
76. Taylor RS, Ashton KE, Moxham T, Hooper L, Ebrahim S. Reduced dietary salt for the prevention of cardiovascular disease. Cochrane Database Syst Rev. 2011;(7):CD009217.
77. Paterna S, Gaspare P, Fasullo S, Sarullo FM, Di Pasquale P. Normal-sodium diet compared with low-sodium diet in compensated congestive heart failure: is sodium an old enemy or a new friend? Clin Sci (Lond). 2008;114(3): 221-230.
78. O'Donnell MJ, Yusuf S, Mente A, et al. Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA. 2011; 306(20): 2229-2238.
79. Ekinci EI, Clarke S, Thomas MC, et al. Dietary salt intake and mortality in patients with type 2 diabetes. Diabetes Care. 2011;34(3): 703-709.
80. Whelton PK, Appel LJ, Sacco RL, et al. Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations. Circulation. 2012;126(24): 2880-2889.
81. Dietary Guidelines for Americans. 7th ed. Washington, DC: US Government Printing Office; 2010.
82. Appel LJ, Frohlich ED, Hall JE, et al. The importance of population-wide sodium reduction as a means to prevent cardiovascular disease and stroke: a call to action from the American Heart Association. Circulation. 2011;123(10): 1138-1143.